Ontstaan van gewrichtsontstekingen bij patiënten met psoriasis
Recruiting
- Conditions
- Psoriasis, Psoriatic Arthritis
- Registration Number
- NL-OMON20950
- Lead Sponsor
- Investigator-initiated
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
* Diagnosis of cutaneous psoriasis
* Inclusion in DAPPER study
* Age 16 years or above
* Willing and able to comply with visits and study-related procedures
* Provide signed informed consent (IC)
Exclusion Criteria
* Medical history with PsA
* Medical history with other immune-mediated or auto-immune rheumatological disease. For example, but not limited to: rheumatoid arthritis, systemic vasculitis, axial spondyloarthritis. Gout, fibromyalgia or osteo-arthritis are not excluded.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study endpoint will be the incidence rate of PsA in Pso patients in the setting of a university dermatology outpatient clinic.
- Secondary Outcome Measures
Name Time Method Secondary endpoints will be the predictive values of several markers to predict the chance of development of PsA.